Skip to main content
. 2017 Aug 25;18(9):1851. doi: 10.3390/ijms18091851

Table 4.

Challenges of aptamer therapeutics.

Challenge Solution
Nucleases mediated degradation Chemical modification
Rapid renal clearance (short half-lives) Increasing the weight of aptamer by conjugating cholesterol or PEG
Cost of production Decrease the usage of aptamer
Toxicity (nonspecific immune activation and polyanionic effects) Cautious modification